The present invention relates to a pharmaceutical composition for the treatment of wounds containing blood plasma or serum and a method for treating wounds effectively by applying said composition to the wound site to normalize the tissue-environment around the site.

ABSTRACT HIGH AFFINITY MELAN-A T CELL RECEPTORS The present invention provides TCRs having an affinity (KD) of less than or equal to 3μM, and/or an off-rate (koff) of 1x10-3 S-1 or slower, for the AAGIGILTV-HLA- A* 0201 complex.. Such TCRs are useful, either alone or associated with a therapeutic agent, for target...

The present invention provides polypeptides having the property of binding to a given Class I pMHC CHARACTERISED IN THAT said polypeptide has a KD for the said given Class I pMHC of less than or equal to 1µM and/or has an off-rate (koff) for the said given Class I pMHC molecule of 2 S-1 or slower AND said polypeptid...

This invention relates to a mutated G-CSF mRNA or cDNA fragment iiaving a deletion of an exon 3 region for use as a diagnostic cancermarker.